1. 25 Prospective multicenter validation of the lupus low disease activity state (LLDAS) treatment target. (April 2019) Authors: Morand, Eric; Golder, Vera; Kandane-Rathnayake, Rangi; Huq, Molla; Nim, Hieu; Louthrenoo, Worawit; Luo, Shue Fen; Lateef, Aisha; Sockalingam, Sargunan; Navarra, Sandra; Hamijoyo, Laniyati; Katsumata, Yasuhiro; Chan, Madelynn; Hoi, Alberta Y; Nikpour, Mandana Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 26 Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study. (April 2019) Authors: Morand, Eric; Golder, Vera; Kandane-Rathnayake, Rangi; Huq, Molla; Nim, Hieu; Louthrenoo, Worawit; Luo, Shue Fen; Lateef, Aisha; Sockalingam, Sargunan; Navarra, Sandra; Hamijoyo, Laniyati; Katsumata, Yasuhiro; Chan, Madelynn; Hoi, Alberta Y; Nikpour, Mandana Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus. Issue 1 (19th October 2018) Authors: Vincent, Fabien B; Slavin, Laura; Hoi, Alberta Y; Kitching, Arthur Richard; Mackay, Fabienne; Harris, James; Kandane-Rathnayake, Rangi; Morand, Eric F Journal: Lupus science & medicine Issue: Volume 5:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study. (September 2021) Authors: Louthrenoo, Worawit; Kasitanon, Nuntana; Morand, Eric; Kandane-Rathnayake, Rangi Journal: Lupus Issue: Volume 30:Number 10(2021) Page Start: 1586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study. (December 2022) Authors: Connelly, Kathryn; Kandane-Rathnayake, Rangi; Hoi, Alberta; Louthrenoo, Worawit; Hamijoyo, Laniyati; Cho, Jiacai; Lateef, Aisha; Fen Luo, Shue; Wu, Yeong-Jian J; Li, Zhanguo; Navarra, Sandra; Zamora, Leonid; Sockalingam, Sargunan; Hao, Yanjie; Zhang, Zhuoli; Katsumata, Yasuhiro; Harigai, Masayosh... Journal: Lancet Issue: Volume 4:Number 12(2022) Page Start: e831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020) Authors: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F Journal: Lupus science & medicine Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020) Authors: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F Journal: Lupus science & medicine Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020) Authors: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F Journal: Lupus science & medicine Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020) Authors: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F Journal: Lupus science & medicine Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Issue 1 (15th June 2020) Authors: Vincent, Fabien B; Kandane-Rathnayake, Rangi; Koelmeyer, Rachel; Harris, James; Hoi, Alberta Y; Mackay, Fabienne; Morand, Eric F Journal: Lupus science & medicine Issue: Volume 7:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗